Searched over 200M research papers
10 papers analyzed
These studies suggest that various laboratory tests, including biomarkers, rapid diagnostic tests, and digital methods, are essential for diagnosing and managing conditions related to hemoglobin and hepatitis B, with a focus on improving accuracy, sensitivity, and feasibility in resource-limited settings.
19 papers analyzed
Hemoglobin (Hb) testing is a fundamental diagnostic tool used to evaluate the oxygen-carrying capacity of blood, diagnose anemia, and monitor various health conditions. This article synthesizes recent research on different methods and technologies for Hb measurement, their accuracy, and their applications in clinical and resource-limited settings.
Automated hematology analyzers are the gold standard for Hb measurement in clinical laboratories. These devices provide accurate and rapid results but are often expensive and require significant infrastructure, making them less suitable for resource-limited settings.
A novel paper-based assay for measuring Hb concentration has been developed to address the need for low-cost, accurate diagnostic tools in resource-limited settings. This method involves depositing a blood sample mixed with Drabkin reagent onto chromatography paper, digitizing the blood stain, and analyzing the color intensity. The paper-based assay has shown high correlation with traditional hematology analyzers, demonstrating its potential for diagnosing anemia in low-income regions.
The Hemoglobin Color Scale (HCS) and digital hemoglobinometers like TrueHb and TouchHb have been evaluated for their diagnostic accuracy in screening for anemia. TrueHb, in particular, has shown high sensitivity and specificity, making it a promising tool for use in outreach settings. However, the non-invasive TouchHb device requires further validation before widespread adoption.
HPLC is an advanced method used to identify and quantify hemoglobin variants (HbV) and hemoglobinopathies (HbP). This technique offers high reproducibility and accuracy, significantly reducing the need for confirmatory testing. HPLC can distinguish between common variants such as HbS, HbC, and HbE, which is crucial for diagnosing conditions like sickle cell disease.
Hemoglobin variants and chemically modified derivatives can interfere with glycohemoglobin (HbA1c) measurements, which are used to monitor long-term glycemic control in diabetes patients. The impact of these variants varies among different assay methods, highlighting the need for laboratories to choose appropriate methods or provide alternative non-Hb-based tests for accurate assessment.
RDTs offer a convenient and quick method for Hb measurement, especially in settings where traditional laboratory infrastructure is lacking. These tests have shown good sensitivity and specificity compared to laboratory-based methods, although their accuracy can vary depending on the brand and patient population.
Innovative non-invasive methods, such as touch-based sweat analysis, have been developed for simultaneous detection of ketone bodies and glucose. This method provides a pain-free alternative for frequent monitoring, particularly useful for individuals managing diabetes or following ketogenic diets.
Hemoglobin testing is essential for diagnosing and managing various health conditions. While traditional methods like automated hematology analyzers remain the gold standard, innovative approaches such as paper-based assays, digital hemoglobinometers, and non-invasive sweat analysis are expanding the possibilities for accurate and accessible Hb measurement in diverse settings. Continued research and development are crucial to improve the accuracy and applicability of these methods, particularly in resource-limited environments.
Most relevant research papers on this topic